Cardiff University:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Cardiff University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9286
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cardiff University is an educational institution that offers education and research services. The institute provides undergraduate courses, post graduate courses, international courses, accommodations and libraries. It conducts research in the areas of engineering and physical sciences, bio-medical and life sciences, and arts, humanities, and social sciences. The institute offers courses in various fields such as accounting, history, language, archaeology, architecture, astrophysics, banking and finance, biology, bio-medical science, biotechnology, business management, chemistry, civil engineering, computer science, criminology, dentistry, ecology, environment, geology, and others. Cardiff University is headquartered in Cardiff, the UK.

Cardiff University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cardiff University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cardiff University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cardiff University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cardiff University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Cardiff University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cardiff University, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Diamyd Medical Enters into Partnership with Cardiff University 10
Licensing Agreements 11
Tiziana Life Sciences Enters into Agreement with Cardiff University 11
Tiziana Life Sciences Enters into Licensing Agreement with Cardiff University 12
Cancer Research Technology, Cardiff University, And Institute of Cancer Research Extend Licensing Agreement With Merck Serono 13
Cardiff University – Key Competitors 15
Cardiff University – Key Employees 16
Cardiff University – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Government and Public Interest 18
Sep 10, 2018: Life Sciences Research Network Congress brings together Wales’ finest Drug Discovery researchers 18
Sep 06, 2018: Cellesce and Cardiff University Win Innovate UK Primer Award to Develop Organoids at Scale to Advance Breast Cancer Research 19
Aug 13, 2018: New insight into genetic drivers of aggressive prostate cancer 20
Apr 17, 2018: Improved method of delivering anti-cancer drugs 21
Dec 12, 2017: Tapeworm drug could lead the fight against Parkinson’s disease 23
Nov 17, 2017: Improved method of engineering T-cells to attack cancer 24
Product News 25
Jul 05, 2018: Potential new drug for two life-threatening diseases 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Cardiff University, Pharmaceuticals & Healthcare, Key Facts 2
Cardiff University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cardiff University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cardiff University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cardiff University, Deals By Therapy Area, 2012 to YTD 2018 8
Cardiff University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Diamyd Medical Enters into Partnership with Cardiff University 10
Tiziana Life Sciences Enters into Agreement with Cardiff University 11
Tiziana Life Sciences Enters into Licensing Agreement with Cardiff University 12
Cancer Research Technology, Cardiff University, And Institute of Cancer Research Extend Licensing Agreement With Merck Serono 13
Cardiff University, Key Competitors 15
Cardiff University, Key Employees 16
Cardiff University, Other Locations 17
Cardiff University, Subsidiaries 17

List of Figures
Cardiff University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Cardiff University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Cardiff University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Cardiff University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cardiff University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Cardiff University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cardiff University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Cardiff University:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Direct Flow Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Direct Flow Medical Inc (Direct Flow) is a medical device company that develops novel transcatheter heart valve technologies. The company provides transcatheter aortic valve implantation device without contrast. It also provides direct flow medical system, a technology for controlled and rel …
  • Xactware Solutions Inc:企業の戦略的SWOT分析
    Xactware Solutions Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • United Natural Foods Inc:企業の戦略・SWOT・財務情報
    United Natural Foods Inc - Strategy, SWOT and Corporate Finance Report Summary United Natural Foods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Constantia Industries AG:企業の戦略的SWOT分析
    Constantia Industries AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Innsuites Hospitality Trust:企業の戦略・SWOT・財務分析
    Innsuites Hospitality Trust - Strategy, SWOT and Corporate Finance Report Summary Innsuites Hospitality Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Motus Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Motus Therapeutics Inc (Motus), formerly Rhythm Pharmaceuticals, Inc. is a subsidiary of Rhythm Holding Company LLC, biotechnology company that provides therapies. The company develops peptide therapeutics for the treatment of metabolic diseases. Its products under clinical development inclu …
  • Pt Bumi Resources Tbk:企業の戦略・SWOT・財務分析
    Pt Bumi Resources Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Bumi Resources Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Pacific Gas and Electric Co:企業の戦略的SWOT分析
    Pacific Gas and Electric Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Pure Technologies Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Pure Technologies Ltd. (Pure Technologies) develops technologies for inspection, monitoring and management of physical infrastructure such as buildings, water and hydrocarbon pipelines, and bridges. It provides proprietary monitoring equipment for pipelines, bridges and structures; technical …
  • United Overseas Bank Ltd:戦略・SWOT・企業財務分析
    United Overseas Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary United Overseas Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates:企業の戦略・SWOT・財務情報
    Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates - Strategy, SWOT and Corporate Finance Report Summary Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • Biofrontera AG (B8F):企業の財務・戦略的SWOT分析
    Biofrontera AG (B8F) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Laricina Energy Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Laricina Energy Ltd (Laricina Energy) is an upstream oil and gas company that explores, produces and develops oil sand properties in Western Canada. The company offers development of underground bitumen deposits in sand and carbonate formations. It operates Germain property and Saleski prope …
  • Jetion Solar (China) Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Jetion Solar (China) Co Ltd (Jetion Solar), a subsidiary of China National Building Material Company Ltd, is an alternative energy company that manufactures solar modules and solar power plants. The company offers solar systems, solar panels, polycrystalline panels, monocrystalline panels, a …
  • NMDC Ltd:企業のM&A・事業提携・投資動向
    NMDC Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NMDC Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Merus NV (MRUS):企業の財務・戦略的SWOT分析
    Summary Merus NV (Merus) is a clinical-stage immuno-oncology company that discovers and develops human bispecific antibody therapeutics for the treatment of cancer. The company’s pipeline antibody candidates are intended for the treatment of breast cancer, ovarian cancer, colorectal cancer, acute my …
  • Genting Singapore Plc:戦略・SWOT・企業財務分析
    Genting Singapore Plc - Strategy, SWOT and Corporate Finance Report Summary Genting Singapore Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • OSI Maritime Systems:企業の戦略・SWOT・財務情報
    OSI Maritime Systems - Strategy, SWOT and Corporate Finance Report Summary OSI Maritime Systems - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Hydro-Quebec:電力:M&Aディール及び事業提携情報
    Summary Hydro-Quebec is a government-owned energy utility that generates, transmits and distributes electricity. The company specializes in renewable energy generation, using hydro sources and supports the development of electricity using other technologies such as wind energy and biomass. It genera …
  • Stifel Financial Corp.:企業のM&A・事業提携・投資動向
    Stifel Financial Corp. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Stifel Financial Corp. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆